Immune to Cancer: The CRI Blog
-
Five Things to Know When Considering Immunotherapy
When former U.S. President Jimmy Carter credited immunotherapy for beating his cancer in 2015, it was a… -
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene… -
ImmunoAdvocate Perspectives: Navigating Cancer Immunotherapy and Survivorship
Sharing one’s cancer survival story is not just a personal act of courage — it has the… -
How Immunotherapy Saved Lenny’s Life
Lenny Weiland’s lung cancer survival story is one that can benefit all of us. The New Jersey… -
Translating Science into Survival at the 8th Annual CICON Conference
CRI is proud to co-host the eighth annual Cancer Immunotherapy Conference (CICON) alongside the European Network for… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
Immunotherapy’s Visible Promise Against Head and Neck Cancer
The drummer for the rock band Poison, Rikki Rockett, has made a name and a living for… -
Can a simple blood test tell you how your cancer therapy works?
According to a recent study published in Nature Medicine, blood from patients can be used to screen… -
Meet Gordon Levine: CRI ImmunoAdvocate, Stage 4 Colorectal Cancer Survivor, and Immunotherapy Champion
CRI ImmunoAdvocate Gordon Levine’s fight against colorectal cancer was not linear. The lawyer-by-trade first sought treatment in…